Global Cancer Pain Market Report 2022-2027: Increase in Number of Cancer Patients & in Healthcare Expenditure Driving 5.12% Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Cancer Pain Market (2022-2027) by Type, Disease Indication, Application, and Geography, Competitive Analysis, Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The Global Cancer Pain Market is estimated to be USD 8.14 Bn in 2022 and is projected to reach USD 10.45 Bn by 2027, growing at a CAGR of 5.12%.

Market Segmentations

The Global Cancer Pain Market is segmented based on Type, Disease Indication, and Geography.

• By Type, the market is classified into Opioids, Non-Opioids, and Nerve Blockers.
• By Disease Indication, the market is classified into Lung Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Blood Cancer, and Others.
• By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific

Countries Studied

• America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
• Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
• Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
• Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

• The report presents a detailed Ansoff matrix analysis for the Global Cancer Pain Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
• The report analyses the Global Cancer Pain Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
• Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

• The report offers a comprehensive evaluation of the Global Cancer Pain Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
• The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
• The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
• The report also contains the competitive analysis using Positioning Quadrants, the analyst's Proprietary competitive positioning tool.

Report Highlights:

• A complete analysis of the market, including the parent industry
• Important market dynamics and trends
• Market segmentation
• Historical, current, and projected size of the market based on value and volume
• Market shares and strategies of key players
• Recommendations to companies for strengthening their foothold in the market

Market Dynamics

Drivers

• Increase in Number of Cancer Patients
• Increasing Geriatric Population
• Increase in Healthcare Expenditure

Restraints

• Adverse Effects Associated with of Use of Drugs Employed in Cancer Pain Management

Opportunities

• Increase in Number of Pipeline Drugs
• Growth Opportunities in Emerging Countries

Challenges

• Absence of a Perfect Pain Management Solution

Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary

4 Market Dynamics

5 Market Analysis

6 Global Cancer Pain Market, By Type

7 Global Cancer Pain Market, By Disease Indication

8 Americas' Cancer Pain Market

9 Europe's Cancer Pain Market

10 Middle East and Africa's Cancer Pain Market

11 APAC's Cancer Pain Market

12 Competitive Landscape

13 Company Profiles

14 Appendix

Companies Mentioned

• Aoxing Pharmaceutical
• Biodelivery Sciences International
• CK Life Sciences
• Daiichi Sankyo
• Eli Lilly & Company
• Grunenthal Pharma
• GW Pharmaceuticals
• Hisamitsu Pharmaceutical
• Kyowa Kirin
• Mundipharma International
• Orexo
• Pfizer
• Roche
• Teva Pharmaceutical Industries

For more information about this report visit https://www.researchandmarkets.com/r/a85cqy

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900